Olympus Corp (OTCMKTS:OCPNY) – Equities research analysts at Jefferies Group issued their Q3 2018 EPS estimates for Olympus in a research note issued to investors on Friday, Zacks Investment Research reports. Jefferies Group analyst M. Nakanomyo forecasts that the company will post earnings of $0.35 per share for the quarter. Jefferies Group also issued estimates for Olympus’ Q4 2018 earnings at $0.40 EPS.
Olympus (OTCMKTS:OCPNY) last posted its quarterly earnings results on Wednesday, November 8th. The company reported $0.52 earnings per share (EPS) for the quarter. Olympus had a return on equity of 14.88% and a net margin of 11.14%.
Separately, Zacks Investment Research upgraded Olympus from a “hold” rating to a “buy” rating and set a $40.00 price objective on the stock in a research report on Wednesday, October 18th.
Olympus (OTCMKTS OCPNY) opened at $37.67 on Monday. The stock has a market capitalization of $12,475.67, a P/E ratio of 16.82, a P/E/G ratio of 2.61 and a beta of 0.97. Olympus has a 1 year low of $33.25 and a 1 year high of $41.87. The company has a current ratio of 1.66, a quick ratio of 1.19 and a debt-to-equity ratio of 0.40.
ILLEGAL ACTIVITY WARNING: This article was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/02/08/olympus-corp-ocpny-to-post-q3-2018-earnings-of-0-35-per-share-jefferies-group-forecasts.html.
Olympus Company Profile
Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.
Get a free copy of the Zacks research report on Olympus (OCPNY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.